Insights into the Biosynthesis of Kibdelomycin and Amycolamicin from Comparative Biosynthetic Gene Cluster Analysis and Precursor Incorporation Studies
- 25 July 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (8) , 1988-1999
Abstract
Kibdelomycin and amycolamicin are identical antibiotics produced by Kibdelosporangium banguiense CA-240109 and Amycolatopsis sp. MK575-fF5, respectively. They are broad-spectrum antibiotics showing potent activity against antibiotic-resistant Gram-positive bacteria. These compounds inhibit DNA gyrase subunit B (GyrB) and topoisomerase IV (ParE) by a unique U-shaped multicontact binding mode and have no cross-resistance to known antibiotics. Kibdelomycin represents a promising scaffold for developing new antibiotics, but its poor production, structural complexity, and chemical stability limit its chemical modification. In this work, we describe the improvement of kibdelomycin production via strain mutagenesis and the elucidation of kibdelomycin biosynthesis using isotope-labeled feeding experiments and sequencing of the kibdelomycin and amycolamicin biosynthetic gene clusters (BGCs), which are similar but not identical. These studies provide avenues for structure-guided biosynthetic analogue development as well as material for chemical modification.Keywords
Funding Information
- Consejer?a de Econom?a, Conocimiento, Empresas y Universidad, Junta de Andaluc?a (PY18-RE-0031)
This publication has 51 references indexed in Scilit:
- Identification of Kibdelomycin and Related Biosynthetic Gene Clusters and Characterization of the C‐Branching of AmycoloseAngewandte Chemie International Edition, 2024
- Transcriptional regulators of secondary metabolite biosynthesis in StreptomycesWorld Journal of Microbiology and Biotechnology, 2024
- TetR and OmpR family regulators in natural product biosynthesis and resistanceProteins: Structure, Function, and Bioinformatics, 2023
- Roles of LuxR-family regulators in the biosynthesis of secondary metabolites in ActinobacteriaWorld Journal of Microbiology and Biotechnology, 2022
- Total Synthesis of KibdelomycinAngewandte Chemie International Edition, 2022
- The Illumina Sequencing Protocol and the NovaSeq 6000 System2021
- Description of Kibdelosporangium banguiense sp. nov., a novel actinomycete isolated from soil of the forest of Pama, on the plateau of Bangui, Central African RepublicAntonie van Leeuwenhoek, 2016
- Kibdelomycin A, a congener of kibdelomycin, derivatives and their antibacterial activitiesBioorganic & Medicinal Chemistry Letters, 2012
- Amycolamicin: A Novel Broad‐Spectrum Antibiotic Inhibiting Bacterial TopoisomeraseChemistry – A European Journal, 2012
- Integrated DNA sequences in three streptomycetes form related autonomous plasmids after transfer to Streptomyces lividansPlasmid, 1984